Piper Jaffray assumes Integra LifeSciences coverage — 5 things to know

Piper Jaffray began coverage of Integra LifeSciences shares in a research note issued yesterday, according to a Sleek Monkey report.

Advertisement

Here are five things to know about Integra LifeSciences:

 

1. Piper Jaffray analysts set an “overweight” rating for the stock.
2. Integra traded up yesterday 0.41 percent.
3. Trading volume was 49,458.
4. Integra’s market cap is $1.94 billion.
5. The stock price hit $59.30 with a 52-week high of $61.26.

 

More articles on orthopedic devices:
Medtronic is headed for strong 2015—8 reasons why
5 spine, orthopedic device launches & releases
Lumin Health names two new executives

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.